Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Merck Sharp & Dohme LLC
Age
0–0
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy 2-month-old full term infants born to non-HBs Ag (hepatitis B virus) carrier mothers
You may not be if
Birth mother known to be a carrier of hepatitis B virus (HBsAg+) or known carriers ever living in close contact with the subject
History of previous hepatitis B infection; history of vaccination with any hepatitis B vaccine
Recent (\<72 hours) history of febrile illness (rectal temperature \>=38.1°C/\>=100.5°F)
Known or suspected hypersensitivity to any component of RECOMBIVAXHB™ or COMVAX™ (e.g., aluminum, yeast)
Recent administration (w/i 3 months prior to study start) of hepatitis B immune globulin (HBIg), serum immune globulin, or any other blood-derived product
Receipt of investigational drugs or investigational vaccines within 3 months prior to study start or if planned within the study period;
Known or suspected impairment of immunologic function or recent use (within 3 months prior to study start) of immunomodulatory medications (does not include topical and inhaled steroids);
Any condition that, in the opinion of the investigator, might interfere with the evaluation of study objectives; or inability to comply with the study schedule and/or inability to attend all required study visits
